Antitumor activity of 5T4-targeting ADC ACR246 and its correlation with 5T4 expression in patient-derived models and a first-in-human study
Science Bulletin · 2026-11
DOI: 10.1016/j.scib.2026.11.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Bulletin, 2026-11. Verfasst von Xi Jiao und 12 weiteren Autor:innen. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Jiao, X., Zhang, P., Zhuo, N., Wang, F., Zhang, M., Gong, J., Dai, Y., Shen, L., Shi, W., Miao, Z., Li, Y., Lu, Z., & Shen, L. (2026). Antitumor activity of 5T4-targeting ADC ACR246 and its correlation with 5T4 expression in patient-derived models and a first-in-human study. Science Bulletin. https://doi.org/10.1016/j.scib.2026.11.005
Vancouver
Jiao X, Zhang P, Zhuo N, Wang F, Zhang M, Gong J, et al. Antitumor activity of 5T4-targeting ADC ACR246 and its correlation with 5T4 expression in patient-derived models and a first-in-human study. Science Bulletin. 2026. doi:10.1016/j.scib.2026.11.005
BibTeX
@article{Jiao2026,
author = {Jiao, Xi and Zhang, Panpan and Zhuo, Na and Wang, Feng and Zhang, Miao and Gong, Jifang and Dai, Yan and Shen, Lixia and Shi, Wenhao and Miao, Zhenwei and Li, Yaowu and Lu, Zhihao and Shen, Lin},
title = {Antitumor activity of 5T4-targeting ADC ACR246 and its correlation with 5T4 expression in patient-derived models and a first-in-human study},
journal = {Science Bulletin},
year = {2026},
doi = {10.1016/j.scib.2026.11.005}
}
EUVIMED